Azithromycin (hydrate) [117772-70-0]
Referência HY-17506A-50mg
Tamanho : 50mg
Marca : MedChemExpress
Please arrange your schedule properly.
- United States
- Canada
- United Kingdom
- Australia
- Germany
- France
- Japan
- Korea South
- Switzerland
- Algeria
- Argentina
- Austria
- Belgium
- Brazil
- Chile
- Croatia
- Czech Republic
- Denmark
- Finland
- Hong Kong, China
- Hungary
- India
- Iraq
- Ireland
- Israel
- Italy
- Lebanon
- Luxembourg
- Malaysia
- Mexico
- Morocco
- Netherlands
- New Zealand
- Norway
- Pakistan
- Peru
- Philippines
- Poland
- Portugal
- Qatar
- Russia
- Saudi Arabia
- Serbia
- Singapore
- Slovakia
- Slovenia
- South Africa
- Spain
- Sweden
- Taiwan, China
- Thailand
- Tunisia
- Turkey
- Ukraine
- Macao, China
- Other Countries
Azithromycin hydrate (Synonyms: CP-62993 dihydrate)
- Cat. No.: HY-17506A Pureté: ≥98.0%
- COA Instruction de manipulation
Azithromycin hydrate is a macrolide antibiotic useful for the treatment of a number of bacterial infections.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
Azithromycin hydrate Chemical Structure
CAS No. : 117772-70-0
Size | Prix | Stock | Quantité |
---|---|---|---|
Échantillon gratuit (0.1 - 0.5 mg) | Appliquer maintenant | ||
50 mg | USD 66 | En stock | |
100 mg | USD 99 | En stock | |
200 mg | USD 154 | En stock | |
500 mg | USD 264 | En stock | |
1 g | Obtenir un devis | ||
5 g | Obtenir un devis |
* Veuillez sélectionner la quantité avant d'ajouter des articles.
This product is a controlled substance and not for sale in your territory.
Avis client
Based on 21 publication(s) in Google Scholar
Other Forms of Azithromycin hydrate:
- Azithromycin In-stock
- Azithromycin-d3 In-stock
21 Publications Citing Use of MCE Azithromycin hydrate
- •Adv Sci (Weinh). 2020 Jul 21;7(17):2001374. [Abstract]
- •Emerg Microbes Infect. 2024 Dec;13(1):2321981. [Abstract]
- •Mol Ther. 2022 Feb 18;S1525-0016(22)00102-2. [Abstract]
- •Theranostics. 2022 Jan 1;12(3):1187-1203. [Abstract]
- •Acta Pharm Sin B. 2021 Mar 11.
- •Cell Rep. 2023 Dec 12;42(12):113563. [Abstract]
- •ACS Omega. March 3, 2022.
- •iScience. 5 January 2022, 103731.
- •Biochem Pharmacol. 2021 Sep 30;114793. [Abstract]
- •Invest Ophthalmol Vis Sci. 2021 Feb 1;62(2):33. [Abstract]
- •Viruses. 2020 Jun 10;12(6):628. [Abstract]
- •Viruses. 2019 Nov 15;11(11):1064. [Abstract]
- •ACS Chem Biol. 2021 Dec 15. [Abstract]
- •Biochem Biophys Res Commun. 2020 Feb 19;522(4):862-868. [Abstract]
- •Research Square Preprint. 2022 Jun.
- •Journal of Pharmaceutical Research International. 33(47B): 274-279, 2021.
- •COVID. 2021, 1(1), 263-275.
- •bioRxiv. 2021 Jan 19.
- •Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Transmissores de Hematozoários. 2020 Sep.
- •Katedra farmakologie a toxikologie. 2020 Jul.
- •Patent. US20200101105A1.
Voir tous les produits spécifiques à Isoform Antibiotic:
Voir tous les produits spécifiques à Isoform Parasite:
Activité biologique
Protocole
Pureté et documentation
Références
Avis client
Description |
Azithromycin hydrate is a macrolide antibiotic useful for the treatment of a number of bacterial infections. |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
IC50 & Target |
|
||||||||||||
In Vitro |
Azithromycin (2 μM) augments rhinovirus-induced IFNβ expression in primary bronchial epithelial cells from asthmatics, which is associated with over-expression of RIG-I like receptors and repression of viral replication. Knockdown of MDA5, but not knockdown of RIG-I, diminishes azithromycin (2 μM)-enhanced viral-induced IFNβ expression in asthmatic primary bronchial epithelial cells[1]. Azithromycin specifically reduces MMP-9 mRNA and protein levels without affecting NF-κB in endotoxin-challenged monocytic THP-1 cells[2]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
In Vivo |
Azithromycin (50 mg/kg) has no effect on bronchoalveolar lavage inflammatory parameters and LDH levels in a mouse model of asthma exacerbation. Azithromycin induces neither general inflammatory parameters nor LDH release in a mouse model of asthma exacerbation, and augments expression of interferon-stimulated genes and the pattern recognition receptor MDA5 but not RIG-I in exacerbating mice[1]. MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. |
||||||||||||
Essai clinique |
|
||||||||||||
Masse moléculaire |
785.02 |
||||||||||||
Formule |
C38H76N2O14 |
||||||||||||
CAS No. | |||||||||||||
Appearance |
Solid |
||||||||||||
Color |
White to off-white |
||||||||||||
SMILES |
C[C@@H]([C@@H]([C@@](C(O[C@@H]([C@@](C)(O)[C@@H]1O)CC)=O)(06)C)O[C@@](O[C@@H](C)[C@@H]2O)(06)C[C@@]2(C)OC)[C@H]([C@](O)(C[C@H](CN([C@@H]1C)C)C)C)O[C@@](O[C@H](C)C[C@@H]3N(C)C)(06)[C@@H]3O.O.O |
||||||||||||
Livraison | Room temperature in continental US; may vary elsewhere. |
||||||||||||
Stockage |
4°C, protect from light, stored under nitrogen *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen) |
||||||||||||
Solvant et solubilité |
In Vitro:
DMSO : 100 mg/mL (127.39 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Preparing
Stock Solutions
View the Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol) Concentration (start) × Volume (start) = Concentration (final) × Volume (final) This equation is commonly abbreviated as: C1V1 = C2V2 In Vivo Dissolution Calculator
Please enter the basic information of animal experiments:
Dosage mg/kgAnimal weight Dosing volume Number of animals Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Calculation results:
Working solution concentration:
mg/mL
|
||||||||||||
Pureté et documentation |
Purity: ≥98.0% |
||||||||||||
Références |
|
Complete Stock Solution Preparation Table
*
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light, stored under nitrogen). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
---|
DMSO | 1 mM | 1.2739 mL | 6.3693 mL | 12.7385 mL | 31.8463 mL |
5 mM | 0.2548 mL | 1.2739 mL | 2.5477 mL | 6.3693 mL | |
10 mM | 0.1274 mL | 0.6369 mL | 1.2739 mL | 3.1846 mL | |
15 mM | 0.0849 mL | 0.4246 mL | 0.8492 mL | 2.1231 mL | |
20 mM | 0.0637 mL | 0.3185 mL | 0.6369 mL | 1.5923 mL | |
25 mM | 0.0510 mL | 0.2548 mL | 0.5095 mL | 1.2739 mL | |
30 mM | 0.0425 mL | 0.2123 mL | 0.4246 mL | 1.0615 mL | |
40 mM | 0.0318 mL | 0.1592 mL | 0.3185 mL | 0.7962 mL | |
50 mM | 0.0255 mL | 0.1274 mL | 0.2548 mL | 0.6369 mL | |
60 mM | 0.0212 mL | 0.1062 mL | 0.2123 mL | 0.5308 mL | |
80 mM | 0.0159 mL | 0.0796 mL | 0.1592 mL | 0.3981 mL | |
100 mM | 0.0127 mL | 0.0637 mL | 0.1274 mL | 0.3185 mL |
Azithromycin hydrate Related Classifications
-
Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.
Keywords:
Azithromycin117772-70-0CP-62993 dihydrateBacterialAutophagyAntibioticParasiteInhibitorinhibitorinhibit
Vos produits récemment consultés:
Demande en ligne
Your information is safe with us. * Required Fields.
Bulk Inquiry
Inquiry Information
- Nom du produit:
- Azithromycin hydrate
- Cat. No.:
- HY-17506A
- Quantité:
- MCE Japan Authorized Agent: